Renal Business Today

Government Accountability Office (GAO)

FDA Announces Plans to Pilot ESRD Technology in New Program

SILVER SPRING, Md.—Three products for patients with end stage renal disease (ESRD) have been chosen to participate in the FDA’s Innovation Pathway, an evolving system designed to help medical devices reach patients in a safe, timely and collaborative manner. ...More
April 9, 2012
Posted in News, Clinical & Pharma
Senators Introduce Bill to Extend Transplant Drug Coverage

WASHINGTON—U.S. Senators Dick Durbin (D-IL), Thad Cochran (R-MS), and Scott Brown (R-MA) have introduced bipartisan legislation that would extend immosuppressive drug coverage for kidney transplant recipients. ...More
August 3, 2011
Posted in News
MedPAC Adds Two New Members

WASHINGTON—The Medicare Payment Advisory Commission (MedPAC) has added two new members to its ranks and has reappointed three existing members. ...More
June 3, 2011
Posted in News, Government & Regulation
GAO: CMS Must Ensure Adequate Payment for Oral Drugs

WASHINGTON—Oral-only ESRD drugs are set to be included in the dialysis bundle in 2014, and the Centers for Medicaid & Medicare Services (CMS) needs to make sure the payments are adequate and that there is reliable data available for monitoring mineral and bone disorder, ...More
March 24, 2011 By Keith Chartier
Posted in Articles, Business, Government & Regulation
Feds Charge Dozens in Largest Medicare Fraud Ever

A network of Armenian gangsters used fake healthcare clinics and other scams in an effort to cheat Medicare out of $163 million, according to U.S. authorities. This is the most extensive fraud by one outlet in the program's history. ...More
October 14, 2010
Posted in News, Government & Regulation, Practice Management
Bundling’s Affect on Home Dialysis Still Unclear

WASHINGTON—In a May report, the Government Accountability Office found that home dialysis is generally cheaper per treatment compared to in-center dialysis, but it also learned that providers have questioned whether a new reimbursement system can increase the use of the ...More
May 27, 2009
Posted in Articles, Business, Clinical & Pharma, Government & Regulation, Practice Management
Viewpoint: The Many Faces of Quality Care and a Need for Accountability

There has been concern regarding quality care and patient safety in dialysis facilities for many years. All patients expect quality safe care when entering any healthcare setting. Patients entering into the dialysis setting, where they will be receiving complicated ...More
June 30, 2008
Posted in Articles, Government & Regulation
Baxter recalls heparin

WASHINGTON—Baxter Healthcare Corp. has stopped manufacturing and has recalled all multiple-dose vials of the injectable blood-thinning drug heparin after receiving more than 300 reports of allergic reactions since the start of the year. Four people have died after receiving ...More
March 20, 2008
Posted in Articles, Business, Government & Regulation